...
机译:树脂与玻璃微球,用于Y-90耳状释放:使用预处理分区模型剂量测定比较不可切除的肝细胞癌的存活
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Radiol &
Intervent Radiol Rue Bugnon 46 CH-1011 Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Inst Radiat Phys Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Radiol &
Intervent Radiol Rue Bugnon 46 CH-1011 Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Lausanne Univ Hosp Dept Nucl Med &
Mol Imaging Lausanne Switzerland;
Y-90; TARE; hepatocellular carcinoma; survival; partition model dosimetry;
机译:树脂与玻璃微球,用于Y-90耳状释放:使用预处理分区模型剂量测定比较不可切除的肝细胞癌的存活
机译:F-18-FDG PET / CT在不可切除的肝细胞癌中Y-90耳状放射性栓塞后预测存活
机译:用钇-90玻璃微球的relarterial放射性栓塞在肝细胞癌管理中节省了ryarterial-90玻璃微球的成本节约
机译:人工神经网络和逻辑回归模型在肝细胞癌手术后预测院内生存的比较
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:玻璃微球经动脉放射栓塞后肝细胞癌患者90Y PET / CT剂量测定的观察者间差异
机译:用钇-90玻璃微球的relarterial放射性栓塞和肝细胞癌管理中的ryrtrium-90玻璃微球节省了医院成本节约